v3.25.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Operating Expenses:        
Research and development $ 182,386 $ 118,861 $ 423,291 $ 484,047
Research and development - related parties 140,372 133,665 275,827 304,207
General and administrative 1,407,657 1,594,212 3,404,265 3,150,952
Total Operating Expenses 1,730,415 1,846,738 4,103,383 3,939,206
Loss From Operations (1,730,415) (1,846,738) (4,103,383) (3,939,206)
Other (Expense) Income:        
Other income 6,483 1,712,702 12,874 2,752,066
Interest expense (2,672) (11,360) (5,327) (27,809)
Change in fair value of derivative liabilities 249 58
Gain on settlement of liabilities 156,928 156,928
Total other (expense) income, net 3,811 1,858,519 7,547 2,881,243
Income (Loss) Before Income Taxes (1,726,604) 11,781 (4,095,836) (1,057,963)
Income tax benefit
Net Income (Loss) (1,726,604) 11,781 (4,095,836) (1,057,963)
Deemed Dividend
Net Income (Loss) Available to Common Stockholders (1,726,604) 11,781 (4,095,836) (1,057,963)
Other Comprehensive Loss:        
Foreign currency translation adjustments (143,435) (20,861) (208,126) (14,401)
Total Comprehensive Loss $ (1,870,039) $ (9,080) $ (4,303,962) $ (1,072,364)
Basic and Diluted Net Income (Loss) per Common Share        
Basic (in Dollars per share) $ (0.3) $ 0.01 $ (0.88) $ (1.42)
Diluted (in Dollars per share) $ (0.3) $ 0.01 $ (0.88) $ (1.42)
Weighted Average Number of Common Shares Outstanding:        
Basic (in Shares) 5,708,126 919,141 4,629,719 745,552
Diluted (in Shares) 5,708,126 919,141 4,629,719 745,552

Source